Authors: MILLER DM PFENNINGS L COHEN L VANDERPLOEG H LANKHORST C POLMAN C GERBAUD L VERNAY D BIOLAY S VLEUGELS L KETELAUER P

Citation: Dm. Miller et al., MEASURING QUALITY-OF-LIFE IN MULTIPLE-SCLEROSIS PATIENTS WITH THE SF-36 IN 4 COUNTRIES, Quality of life research, 6(7-8), 1997, pp. 258-258

Authors: DOSTERT P BENEDETTI MS PERSIANI S LACROIX R BOSC M FIORENTINI F DEFFOND D VERNAY D DORDAIN G

Citation: P. Dostert et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN THE SELECTIVE DOPAMINE AGONIST CABERGOLINE AND THE MAO-B INHIBITOR SELEGILINE, Journal of neural transmission. Supplementum, (45), 1995, pp. 247-257

Authors: DUBOST JJ VERNAY D SOUBRIER M CAUHAPE P BUSSIERE JL SAUVEZIE B

Citation: Jj. Dubost et al., VERTEBRAL COMPRESSION FRACTURES IN EPILEPTICS - ANALYSIS OF 8 CASES, La Revue de medecine interne, 14(5), 1993, pp. 294-296

Authors: CLAVELOU P VERNAY D CUOQ N SOUBRIER M DHOMBRES A DORDAIN G TOURNILHAC M

Citation: P. Clavelou et al., DEMYELINATING NEUROPATHIES IN BORRELIOSIS, Revue neurologique, 149(5), 1993, pp. 320-325